BIO-11006 Inhalation Solution: Phase I data

In a double-blind, placebo-controlled Phase I trial (BIM-CL-002) in 59 volunteers, single and multiple doses of BIO-11006 were safe and well tolerated. The company plans to begin a Phase II trial in C...